Neoadjuvant immunotherapy in geriatric patients with non–small cell lung cancer: A real-world analysis
Authors:
- Jordan DourlainJDJordan Dourlain
- Omar BusharaOBOmar Bushara
- Mohammad Saad FarooqMFMohammad Saad Farooq
- Julia GasiorJGJulia Gasior
- Karina BruestleKBKarina Bruestle
- Jarrod PredinaJPJarrod Predina
- Doraid JarrarDJDoraid Jarrar
- Giorgos KarakousisGKGiorgos Karakousis
- John C. KucharczukJKJohn C. Kucharczuk
- Sunil SinghalSSSunil Singhal
Open Access
- 3 July 2026
- journal article
- Published by Elsevier in JTCVS Open
- Vol. 33
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Tolerability of immune checkpoint inhibitors for cancer treatment in frail, older patientsJournal of Geriatric Oncology, 2025
- Management of Patients With Early-Stage Non-Small Cell Lung CancerChest, 2025
- Comparison of Survival Outcomes of Early‐Stage Non‐Small‐Cell Lung Cancer in Elderly Patients (≥ 70 years) Treated With Stereotactic Body Radiotherapy Versus Surgical ResectionWorld Journal of Surgery, 2025
- Impacts of Positive Margins and Surgical Extent on Outcomes After Early-Stage Lung Cancer ResectionThe Annals of Thoracic Surgery, 2024
- Open, Video- and Robot-Assisted Thoracoscopic Lobectomy for Stage II-IIIA Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2022
- Immunotherapy in older patients with cancerBiomedical Journal, 2021
- Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III TrialJournal of Thoracic Oncology, 2020
- Does patient age influence anti-cancer immunity?Seminars in Immunopathology, 2018
- Postoperative Outcome After Pulmonary Surgery for Non-Small Cell Lung Cancer in Elderly PatientsThe Annals of Thoracic Surgery, 2018
- Early Stage Non–Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database AnalysisClinical Lung Cancer, 2016